Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in EUR
The 5 analysts offering 12 month price targets for Innate Pharma SA (ADR) have a median target of 8.04, with a high estimate of 11.55 and a low estimate of 2.51. The median estimate represents a 257.17% increase from the last price of 2.25.
High | 413.4% | 11.55 |
Med | 257.2% | 8.04 |
Low | 11.6% | 2.51 |
Earnings history & estimates in EUR
Average growth rate | -6.54% |
More ▼
Revenue history & estimates in EUR
Average growth rate | +14.62% |
More ▼